Quarter Period Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7305469

Concept 2024-03-01 to
2024-08-31
2023-03-01 to
2023-08-31
Quarter period statement of income
Statement of income
Net sales
75,456,000,000 JPY
66,977,000,000 JPY
Cost of sales
31,047,000,000 JPY
28,330,000,000 JPY
Gross profit (loss)
44,408,000,000 JPY
38,646,000,000 JPY
Selling, general and administrative expenses
35,402,000,000 JPY
30,250,000,000 JPY
Selling, general and administrative expenses
Advertising expenses
8,005,000,000 JPY
6,823,000,000 JPY
Operating profit (loss)
9,006,000,000 JPY
8,396,000,000 JPY
Non-operating income
Interest income
1,461,000,000 JPY
1,128,000,000 JPY
Dividend income
648,000,000 JPY
567,000,000 JPY
Non-operating income
2,555,000,000 JPY
3,336,000,000 JPY
Non-operating expenses
Interest expenses
16,000,000 JPY
7,000,000 JPY
Non-operating expenses
773,000,000 JPY
91,000,000 JPY
Ordinary profit (loss)
10,788,000,000 JPY
11,640,000,000 JPY
Extraordinary income
Extraordinary income
2,315,000,000 JPY
JPY
Extraordinary losses
Extraordinary losses
2,000,000 JPY
2,000,000 JPY
Profit (loss) before income taxes
13,101,000,000 JPY
11,638,000,000 JPY
Income taxes
3,700,000,000 JPY
2,967,000,000 JPY
Profit (loss)
9,401,000,000 JPY
8,671,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.